OTC Pharmaceuticals - Italy | Statista Market Forecast

The OTC Pharmaceuticals market in Italy is projected to generate a revenue of US$4.79bn in 2024.
It is expected to grow annually at a rate of 2.46% (CAGR 2024-2029).
Among the various markets, the largest one is Other OTC Pharmaceuticals, with a market volume of US$1.52bn in 2024.
In a global perspective, the United States leads in terms of revenue generation, with US$41.24bn in 2024.
When considering the population size, the per person revenues in Italy are estimated to be US$81.63 in 2024.
Furthermore, it is anticipated that 18.34% of the total revenue in the OTC Pharmaceuticals market will be generated through online sales by 2024.
Italy's OTC Pharmaceuticals market is witnessing a surge in demand for natural remedies, driven by a growing preference for traditional and herbal medicine.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Italy has been experiencing steady growth in recent years. Customer preferences for self-medication, convenience, and affordability have been driving this trend. Additionally, local special circumstances and underlying macroeconomic factors have also played a role in shaping the market.Customer preferences in Italy have shifted towards self-medication due to the convenience it offers. Consumers are increasingly looking for over-the-counter options for common ailments and minor health issues. This preference can be attributed to the ease of access and the ability to treat minor ailments without the need for a doctor's prescription. Furthermore, the affordability of OTC pharmaceuticals compared to prescription drugs has also been a key factor driving customer preferences.Trends in the OTC Pharmaceuticals market in Italy have also been influenced by global and regional market developments. The increasing prevalence of chronic diseases and lifestyle-related health issues has led to a greater demand for OTC medications. This trend is in line with the global rise in non-communicable diseases and the growing need for self-care options. Additionally, the aging population in Italy has also contributed to the growth of the OTC Pharmaceuticals market, as older individuals often require medications for chronic conditions.Local special circumstances in Italy have also played a role in shaping the OTC Pharmaceuticals market. Italy has a strong tradition of herbal medicine and natural remedies, which has influenced consumer preferences for OTC products. Many Italians prefer natural and herbal remedies for common ailments, leading to a demand for OTC products that cater to these preferences. This has created opportunities for companies to develop and market herbal and natural OTC pharmaceuticals in the country.Underlying macroeconomic factors have also contributed to the growth of the OTC Pharmaceuticals market in Italy. The country's healthcare system is under strain due to rising healthcare costs and an aging population. As a result, there has been a greater emphasis on self-care and prevention, leading to increased demand for OTC products. Additionally, the economic downturn in recent years has also led to a greater focus on cost-effective healthcare solutions, further driving the growth of the OTC Pharmaceuticals market.In conclusion, the OTC Pharmaceuticals market in Italy has been experiencing steady growth due to customer preferences for self-medication, convenience, and affordability. Global and regional market trends, local special circumstances, and underlying macroeconomic factors have all played a role in shaping this market. As the demand for self-care options continues to rise, the OTC Pharmaceuticals market in Italy is expected to further expand in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.